Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bevacizumab|DRUG: carboplatin|DRUG: nab-paclitaxel|PROCEDURE: Surgery|DRUG: Adjuvant chemotherapy
Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: Celgene Corporation|Genentech, Inc.